Novo valuation surpasses Tesla on experimental obesity drug data
Go back to Novo valuation surpasses Tesla on experimental obesity drug data| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1152.44 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1152.44 | 52 Week High | $88.16 | |||
| Open | $1152.44 | 52 Week Low | $67.88 | |||
| Day High | $1152.44 | P/E | 266.77 | |||
| Day Low | $1152.44 | EPS | $4.32 | |||
| Volume | 1,496 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 43.19 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.19 | 52 Week High | $59.00 | |||
| Open | $43.19 | 52 Week Low | $32.80 | |||
| Day High | $43.19 | P/E | N/A | |||
| Day Low | $43.19 | EPS | $0.00 | |||
| Volume | 97,897 | |||||
| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 29.36 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.36 | 52 Week High | $5.17 | |||
| Open | $29.36 | 52 Week Low | $0.94 | |||
| Day High | $29.36 | P/E | N/A | |||
| Day Low | $29.36 | EPS | $0.00 | |||
| Volume | 878 | |||||

